NCT06899061 2026-03-03Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of SaruparibAstraZenecaPhase 1 Active not recruiting41 enrolled
NCT05470283 2025-10-20Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic MelanomaM.D. Anderson Cancer CenterPhase 1 Active not recruiting21 enrolled